Balloon angioplasty for intracranial atherosclerotic disease periprocedural risks and short-term outcomes in a multicenter study

Stroke

Volumn 42, Issue 1, 2011, Pages 107-111

  Nguyen, Thanh N ^a   Zaidat, Osama O ^b   Gupta, Rishi ^c,d   Nogueira, Raul G ^d   Tariq, Nauman ^e   Kalia, Junaid S ^b   Norbash, Alexander M ^a   Qureshi, Adnan I ^e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Angioplasty and stenting; Complications; Intracranial disease; Intracranial stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HYPOCHOLESTEROLEMIC AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRACRANIAL ATHEROSCLEROTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTICENTER STUDY (TOPIC); PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RETREATMENT; RISK ASSESSMENT; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS;

EID: 79451475119     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.583245     Document Type: Article

References (24)

1. Chimowitz MI, Lynn MJ, Holett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
2. Derdeyn CP, Chimowitz MI. Re: Turk et al and the 'How do we spin Wingspan?' Commentary. AJNR Am J Neuroradiol. 2008;29:E69.
3. Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, Rasmussen PA, Suri MF, Taylor RA, Zaidat OO. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging. 2009;19(suppl 1):1S-10S.
4. Qureshi AI, Suri MF, Siddiqui AM, Kim SH, Boulos AS, Ringer AJ, Lopes DK, Guterman LR, Hopkins LN. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2005;15:240-249.
5. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388-1392.
6. Kurre W, Berkefeld J, Sitzer M, Neumann-Haefelin T, du Mesnil de Rochemont R. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology. 2008;50:701-708.
7. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke. 2008;39:1766-1769.
8. Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery. 2007;61:644-650.
9. Albuquerque FC, Levy EI, Turk AS, Niemann DB, Aagaard-Kienitz B, Pride GL Jr, Purdy PD, Welch BG, Woo HH, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery. 2008;63:23-27.
10. Turk AS, Levy EI, Albuquerque FC, Pride GL Jr, Woo H, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella D. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol. 2008;29:23-27.
11. Turan T, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M; Warfarin- Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115:2969-2975.
12. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol. 2005;26:525-530.
13. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643-646.
14. Qureshi AI, Hussein HM, El-Gengaihy A, Abdelmoula M, Suri MF. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2008;62:1053-1060.
15. Meyers PM, Schumacher HC, Alexander MJ, et al; Writing Group for the American Academy of Neurology; AANS/CNS Cerebrovascular Section; Society of NeuroInterventional Surgery; Society of Vascular & Interventional Neurology. Performance and training standards for endovascular ischemic stroke treatment. AJNR Am J Neuroradiol. 2010;31:E8-E11.
16. Kasner S, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesh CG, Sila CA, Jovin TG, Romano JG, Cloft HG; for the WASID trial investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
17. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Lynn MJ, Chimowitz M; for the NIH Registry Group. NIH Registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70:1518-1524.
18. Schumacher HC, Meyers PM, Higashida RT, Derdeyn CP, Lavine SD, Nesbit GM, Sacks D, Rasmussen P, Wechsler LR. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. J Vasc Interv Radiol. 2009;20:S451-S473.
19. Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Chimowitz MI; for the NIH Multicenter Wingspan Intracranial Stent Registry Study Group. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009;72:2014-2019.
20. Fiorella DJ, Levy EI, Turk AS, Albuquerque FC, Pride GL Jr, Woo HH, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. Target lesion revascularization after Wingspan: assessment of safety and durability. Stroke. 2009; 40:106-110.
21. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet. 2004;364: 331-337.
22. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ III. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006;27:1882-1892.
23. Siddiq F, Vazquez G, Memon MZ, Suri MF, Taylor RA, Wojak JC, Chaloupka JC, Qureshi AI. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases. A multicenter study. Stroke. 2008;39:2505-2510.
24. Siddiq F, Memon MZ, Vazquez G, Safdar A, Qureshi AI. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery. 2009;65:1024-1033.